Literature DB >> 6316394

Effect of selective monoamine oxidase inhibition by clorgyline and deprenyl on the norepinephrine receptor-coupled adenylate cyclase system in rat cortex.

R Mishra, D D Gillespie, M B Youdim, F Sulser.   

Abstract

The consequences of selective monoamine oxidase (MAO) inhibition on the norepinephrine(NE)-sensitive adenylate cyclase system were determined in slices of rat cerebral cortex. The chronic administration of clorgyline, which selectively inhibited the activity of MAO-A, caused a significant decrease in the responsiveness of the noradrenergic cyclic AMP-generating system. The noradrenergic subsensitivity was accompanied by a significant decrease in the density of beta-adrenoceptors, as measured by 3H-dihydroalprenolol (DHA) binding, without altering the Kd value. However, selective inhibition of MAO-B by deprenyl did not alter the sensitivity of the cyclic AMP-generating system to NE or the specific DHA binding. The basal levels of cyclic AMP in the cortex were unaltered by the drugs. Since inhibition of MAO-A, but not MAO-B, increases the availability of NE, the results support the hypothesis that a persistent NE-receptor interaction is one of the prerequisites for the in vivo densitization of the NE-sensitive adenylate cyclase and the concomitant down-regulation of the number of beta-adrenoceptors in brain.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6316394     DOI: 10.1007/bf00427265

Source DB:  PubMed          Journal:  Psychopharmacology (Berl)        ISSN: 0033-3158            Impact factor:   4.530


  25 in total

1.  Intact presynaptic terminals required for beta-adrenergic receptor regulation by desipramine.

Authors:  J W Schweitzer; R Schwartz; A J Friedhoff
Journal:  J Neurochem       Date:  1979-07       Impact factor: 5.372

2.  Evidence for dopamine deamination by both type A and type B monoamine oxidase in rat brain in vivo and for the degree of inhibition of enzyme necessary for increased functional activity of dopamine and 5-hydroxytryptamine.

Authors:  A R Green; B D Mitchell; A F Tordoff; M B Youdim
Journal:  Br J Pharmacol       Date:  1977-07       Impact factor: 8.739

Review 3.  The use of selective monoamine oxidase inhibitor drugs to modify amine metabolism in brain.

Authors:  N H Neff; H Y Yang; J A Fuentes
Journal:  Adv Biochem Psychopharmacol       Date:  1974

4.  Some puzzling pharmacological effects of monoamine oxidase inhibitors.

Authors:  J Knoll; K Magyar
Journal:  Adv Biochem Psychopharmacol       Date:  1972

5.  Some observations upon a new inhibitor of monoamine oxidase in brain tissue.

Authors:  J P Johnston
Journal:  Biochem Pharmacol       Date:  1968-07       Impact factor: 5.858

6.  Role of neuronal signal input in the down-regulation of central noradrenergic receptor function by antidepressant drugs.

Authors:  A Janowsky; L R Steranka; D D Gillespie; F Sulser
Journal:  J Neurochem       Date:  1982-07       Impact factor: 5.372

7.  On the mode of action of L-deprenyl in the human central nervous system.

Authors:  P Riederer; M B Youdim; W D Rausch; W Birkmayer; K Jellinger; D Seemann
Journal:  J Neural Transm       Date:  1978       Impact factor: 3.575

8.  Effects of monoamine oxidase inhibition by clorgyline, deprenil or tranylcypromine on 5-hydroxytryptamine concentrations in rat brain and hyperactivity following subsequent tryptophan administration.

Authors:  A R Green; M B Youdim
Journal:  Br J Pharmacol       Date:  1975-11       Impact factor: 8.739

9.  Antidepressant potentiation of 5-hydroxytryptophan by L-deprenil in affective illness.

Authors:  J Mendlewicz; M B Youdim
Journal:  J Affect Disord       Date:  1980-06       Impact factor: 4.839

10.  alpha 2-Adrenoreceptors in rat brain are decreased after long-term tricyclic antidepressant drug treatment.

Authors:  C B Smith; J A Garcia-Sevilla; P J Hollingsworth
Journal:  Brain Res       Date:  1981-04-06       Impact factor: 3.252

View more
  1 in total

1.  A pivotal role for serotonin (5HT) in the regulation of beta adrenoceptors by antidepressants: reversibility of the action parachlorophenylalanine by 5-hydroxytroptophan.

Authors:  D H Manier; D D Gillespie; L R Steranka; F Sulser
Journal:  Experientia       Date:  1984-11-15
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.